tirzepatide news update Lilly's weight-loss drug removed from FDA's shortage list FDA confirms tirzepatide shortage is

"Vitamin B 12 deficiency"

Start your intake What Does Cinnamon Actually Do to GLP-1

Contraindications: Active uveal inflammation Most cases of angle-closure glaucoma , due to the possibility of increasing angle block Hypersensitivity to the active or inactive ingredients Side Effects: Retinal detachment has been reported in a few cases Stinging, burning, lacrimation Iris cysts may form Lens opacities Cardiac irregularities Pharmacokinetics: Administered in eye drops to patients with glaucoma ) Forms an irreversible covalent bond with the ACh binding site on cholinesterase (duration of action is ~100 hrs Drug Interactions: Potentiates other cholinesterase inhibitors such as succinylcholine or organophosphate and carbamate insecticides Patients undergoing systemic anticholinesterase treatment should be warned of the possible additive effects References: Merck Manual Professional Edition (2026): Medications Used to Treat Glaucoma

4 Single-dose prefilled pens Lilly Package Label (Zepbound, 12.5 mg/0.5 mL, Carton, 4 Single-Dose Pens) PACKAGE LABEL - Zepbound, 15 mg/0.5 mL, Carton, 4 Single-Dose Pens NDC 0002-2457-80 Zepbound (tirzepatide) injection 15 mg/0.5 mL 4 x 15 mg/0.5 mL prefilled pens Rx Only For Subcutaneous Use Dispense enclosed Medication Guide to each patient

Gautam D et al

Mora, A